NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior NotesAccesswire • 01/07/21
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior NotesAccesswire • 01/05/21
NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare ConferenceAccesswire • 01/04/21
NeoGenomics: ~27% Upside Potential Is Under-Reflected, Market Is Unfairly Discounting SharesSeeking Alpha • 12/22/20
NeoGenomics, Inc.'s (NEO) CEO Doug VanOort on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/27/20
NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/28/20
Neogenomics Inc. (NEO) CEO Doug VanOort on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/28/20
NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/27/20